End-of-day quote
Other stock markets
|
||
- USD | - |
Financials (USD)
Sales 2024 * | 60.03B | Sales 2025 * | 62.58B | Capitalization | 145B |
---|---|---|---|---|---|
Net income 2024 * | 6.92B | Net income 2025 * | 9.43B | EV / Sales 2024 * | 3.21 x |
Net Debt 2024 * | 47.04B | Net Debt 2025 * | 41.91B | EV / Sales 2025 * | 2.99 x |
P/E ratio 2024 * |
18.6
x | P/E ratio 2025 * |
13.6
x | Employees | - |
Yield 2024 * |
6.6% | Yield 2025 * |
6.77% | Free-Float | 59.09% |
Latest transcript on Pfizer Inc
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
1st Jan change | Capi. | |
---|---|---|
+28.46% | 673B | |
+24.81% | 551B | |
-7.98% | 348B | |
+14.56% | 317B | |
+5.81% | 288B | |
+2.47% | 210B | |
-0.02% | 204B | |
-9.98% | 195B | |
-7.95% | 142B |